Equities

Firebrick Pharma Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
FRE:ASX

Firebrick Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.053
  • Today's Change-0.004 / -7.02%
  • Shares traded15.05k
  • 1 Year change-36.90%
  • Beta1.3137
Data delayed at least 20 minutes, as of Feb 20 2026 01:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Friday, Firebrick Pharma Ltd (FRE:ASX) closed at 0.053, 6.00% above its 52-week low of 0.05, set on Dec 30, 2025.
52-week range
Today
0.05Dec 30 20250.10Mar 13 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open0.053
High0.053
Low0.053
Bid0.054
Offer0.066
Previous close0.057
Average volume75.84k
Shares outstanding252.48m
Free float151.15m
P/E (TTM)--
Market cap15.15m AUD
EPS (TTM)-0.0126
AUD
Data delayed at least 20 minutes, as of Feb 20 2026 01:56 GMT.
More ▼

Events & Activity

  • FRE:ASX trading volume exceeds daily average by +74.14%
  • FRE:ASX price rises above 50-day moving average to 0.067 at 22:59 GMT
  • FRE:ASX price moved over +6.35% to 0.067
  • FRE:ASX price falls below 50-day moving average to 0.06 at 01:29 GMT
  • FRE:ASX price rises above 15-day moving average to 0.067 at 22:59 GMT
  • FRE:ASX price rises above 15-day moving average to 0.065 at 01:27 GMT
  • FRE:ASX price rises above 15-day moving average to 0.065 at 23:36 GMT
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.